Future of adenoviruses in the gene therapy of arthritis
Recombinant adenoviruses are straightforward to produce at high titres, have a promiscuous host-range, and, because of their ability to infect nondividing cells, lend themselves to in vivo gene delivery. Such advantages have led to their widespread and successful use in preclinical studies of arthri...
Spremljeno u:
| Izdano u: | Arthritis Res |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2001
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC128890/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11299054/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/ar291 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|